Before You Hire a CRO, Read This

The CRO search usually starts in a board meeting. Revenue missed plan, the pipeline looks thin, and someone says the company has outgrown its sales leadership. Within a week there is a search firm on the phone and a job description circulating. I understand the impulse, because I have been the person that search was meant to find. But after 25 years leading commercial organizations in healthcare, I can tell you that most growth-stage companies open a CRO search about a year before they should, and it costs them dearly.

Before you sign the retained search agreement, answer these five questions honestly.

1. Is your go-to-market motion validated, or still being figured out?

A CRO is at their best scaling a machine that already works: a proven buyer, a repeatable sales motion, a pricing model that holds. If you cannot yet describe who buys, why they buy, and how long it takes them to buy, you do not have a scaling problem. You have a design problem, and hiring a permanent operator to solve a design problem is how companies burn a year and a search fee learning the difference.

2. Is the problem really leadership?

In healthcare especially, a stalled pipeline often traces back to something upstream of the sales team: an unclear clinical value story, a buyer committee you have not mapped, a reimbursement dynamic working against you, or a service that solves a problem the health system does not budget for. A new CRO inherits those problems; they do not erase them. Diagnose before you hire, because the wrong diagnosis leads to the most expensive prescription.

3. Can your revenue base carry the fully loaded cost?

A credible full-time healthcare CRO represents a significant first-year commitment once you count total compensation, search fees, and supporting investment, plus meaningful equity. For a company doing $30 million in revenue, that is a rounding decision. For a company doing $6 million, it is a bet-the-year decision.

4. Is there a machine for them to run?

A CRO without a sales team, a CRM discipline, a marketing engine, and a defined territory model spends their first year building infrastructure, which is work a fractional leader can do at a fraction of the cost and dilution. If the org chart under the CRO box is mostly empty, you are not hiring an executive. You are hiring a very expensive builder who expects to run something.

5. Are you hiring for the next 12 months or the next 5 years?

Builders and scalers are different executives, and healthcare punishes companies that confuse them. If the next 12 months are about designing the commercial engine, proving the enterprise motion, and landing the first anchor accounts, hire for that. If the next five years are about running a large organization against a validated playbook, hire for that instead. Companies that need the first and hire for the second end up replacing the CRO within two years, which resets everything.

When the full-time hire is right

If you answered yes to a validated motion, a real infrastructure, a revenue base above roughly $20 million to $30 million, and a scaling mandate, open the search with confidence and hold out for someone with healthcare-specific pattern recognition. Selling clinical and operational services into health systems, hospitals, and physician practices is its own discipline, and generalist revenue leaders underestimate it.

When it is not, there is a better sequence

Bring in fractional CRO or Chief Growth Officer leadership to design, build, and prove the commercial engine first. Then, when the revenue base and infrastructure justify it, make the full-time hire into a working machine, which dramatically improves the odds that hire succeeds. That sequencing is the work I do at Harborline Growth Advisory for commercial-stage, tech-enabled healthcare services companies, built on 25 years of enterprise healthcare relationships.

If you are in the middle of this decision, I am glad to pressure-test it with you before the search fee is spent. Reach out through harborlinegrowth.com.